Crossmark

Daily use of extracorporeal CO2 removal in a critical care unit: indications and results

Crossref DOI link: https://doi.org/10.1186/s40560-018-0304-x

Published Online: 2018-06-28

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Winiszewski, Hadrien https://orcid.org/0000-0002-3728-2334
Aptel, François

Belon, François

Belin, Nicolas

Chaignat, Claire

Patry, Cyrille

Clermont, Cecilia

David, Elise

Navellou, Jean-Christophe

Labro, Guylaine

Piton, Gaël

Capellier, Gilles
License Information

Text and Data Mining valid from 2018-06-28
More Information

Article History

Received: 23 March 2018

Accepted: 7 June 2018

First Online: 28 June 2018

Consent for publication

: According to French law, written inform consent is not required for a retropective case series. All patients (or proxy) admitted in our ICU are informed that medical data may be used for research. If they wish, they may refuse that (approved by an Ethic Committee on March 2013). In this clinical case, no opposition was expressed for using data for research.

: Pr Capellier has received lecture fees from Baxter and Alung. Prismalung® devices were provided by Baxter. The other authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.